{"url_path":"/sec/tela/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1561921/0001104659-26-060234-index.html","accession_number":"0001104659-26-060234","cik":"0001561921","ticker":"TELA","issuer_name":"TELA Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1561921/0001104659-26-060234-index.html","primary_entity_key":"0001561921","primary_entity_name":"TELA Bio, Inc."},"word_count":371,"has_tables":true,"body_markdown":"**Item 6. Exhibits.**\n\n​\n\nThe following exhibits are being filed herewith:\n\n​\n\n**EXHIBIT INDEX**\n\n​\n\n**Exhibit No.**\n\n**  ​ ​ ​**\n\n**Exhibit**\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n31.1\n\n​\n\n[Certification of Chief Executive Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).](tela-20260331xex31d1.htm)\n\n31.2\n\n​\n\n[Certification of Chief Financial Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).](tela-20260331xex31d2.htm)\n\n32.1\n\n​\n\n[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).](tela-20260331xex32d1.htm)\n\n32.2\n\n​\n\n[Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).](tela-20260331xex32d2.htm)\n\n101 INS\n\n​\n\nInline XBRL Instance Document (filed herewith).\n\n101 SCH\n\n​\n\nInline XBRL Taxonomy Extension Schema Document (filed herewith).\n\n101 CAL\n\n​\n\nInline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).\n\n101 DEF\n\n​\n\nInline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).\n\n101 LAB\n\n​\n\nInline XBRL Taxonomy Extension Label Linkbase Document (filed herewith).\n\n101 PRE\n\n​\n\nInline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).\n\n104\n\n​\n\nCover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).\n\n​\n\n​\n\n​\n\n​\n\n​\n\n32\n\n[Table of Contents](#TOC)\n\n**SIGNATURES**\n\n​\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n​\n\n​\n\n​\n\n​\n\n​\n\n**TELA BIO, INC.**\n\n​\n\n​\n\n​\n\nDate: May 13, 2026\n\nBy:\n\n/s/ ANTONY KOBLISH\n\n​\n\n​\n\nAntony Koblish\n\n​\n\n​\n\n*Chief Executive Officer*\n\n​\n\n​\n\n*(Principal executive officer)*\n\n​\n\n​\n\n​\n\nDate: May 13, 2026\n\nBy:\n\n/s/ ROBERTO CUCA\n\n​\n\n​\n\nRoberto Cuca\n\n​\n\n​\n\nChief Operating Officer, Chief Financial Officer and Corporate Secretary\n\n​\n\n​\n\n*(Principal financial officer)*\n\n​\n\n​\n\n​\n\nDate: May 13, 2026\n\nBy:\n\n/s/ MEGAN SMEYKAL\n\n​\n\n​\n\nMegan Smeykal\n\n​\n\n​\n\nChief Accounting Officer and Controller\n\n​\n\n​\n\n*(Principal accounting officer)*\n\n​\n\n​\n\n​\n\n​\n\n​\n\n33"}